A Phase 2b Randomized, Double-blind, Placebo-controlled, 12-week Study to Evaluate the Safety and Efficacy of ALKS 37 in Subjects With Opioid-induced Constipation.
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2014
At a glance
- Drugs Methylsamidorphan (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Alkermes
- 06 Aug 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.